Adults

Lactobacillus acidophilus – LA02 (DSM 21717)

 Rebalance of intestinal microbiota • Oxalate degradation • Reduction of intestinal inflammation • Potential reduction of kidney stones incidence 

Bifidobacterium longum – 04 (DSM 23233)

Restoration of a better dietary ω-6/ω-3 balance • Conjugated linoleic acids (CLA) production • Prospective use in the treatment of obesity • Cholesterol management

Bifidobacterium longum – BL03 (DSM 16603)

Constipation • Intestinal transit • Oxalate degradation • Reduction of intestinal inflammation • Potential reduction of kidney stones incidence

Bifidobacterium longum – W11 (LMG P-21586)

Reduction of gastro-intestinal discomfort related to IBS • Rebalance of intestinal microbiota • Non-transmissible rifamycins resistance • Production of Exopolysaccharides • Hepatic encephalopathy

Bifidobacterium lactis – MB2409 (DSM 23733)

Cardiovascular health • Cholesterol lowering

Bifidobacterium lactis – BS05 (DSM 23032)

Antioxidant activity • Reduced glutathione (GSH) and superoxide dismutase (SOD) production

Bifidobacterium infantis – BI02 (DSM 24687, formerly MB287)

Cardiovascular health • Cholesterol lowering

Bifidobacterium breve – MB113 (DSM 23732)

Cardiovascular health • Cholesterol lowering

Bifidobacterium breve – B632 (DSM 24706)

Inhibition of pathogens E. coli and Enterobacteriaceae

Bifidobacterium breve – BR03 (DSM 16604)

Constipation • Intestinal transit • Anti-inflammatory • Reduction of gastro-intestinal discomfort • Inhibition of pathogenic E. coli • Restoration of a better dietary ω-6/ω-3 balance • Conjugated linoleic acids (CLA) production…

Subscribe to MicrobiomePost newsletter

Take full advantage of MicrobiomePost‘s features.

Scroll to Top